Based on the “cholinergic hypothesis” of AD [2], several classes of acetylcholinesterase (AChE) inhibitors have been identified [3], leading eventually to the discovery of galantamine, donepezil, and rivastigmine. Here, ACHE is linked to Alzheimer disease.